טוען...
Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go(®) Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis
Insulin therapy is frequently required to achieve glycemic targets (A1c) in type 2 diabetes (T2D); however, clinicians and patients face barriers with the complexities of multiple daily injection regimens. Patch-like wearable insulin devices, such as V-Go, may simplify and optimize this complexity....
שמור ב:
| הוצא לאור ב: | Pharmacy (Basel) |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7712908/ https://ncbi.nlm.nih.gov/pubmed/33202616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmacy8040215 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|